Stay updated on ZUMA-2 Study Brexuca Clinical Trial
Sign up to get notified when there's something new on the ZUMA-2 Study Brexuca Clinical Trial page.

Latest updates to the ZUMA-2 Study Brexuca Clinical Trial page
- Check2 days agoChange DetectedUpdated page revision to v3.3.4; the previous revision v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check9 days agoChange DetectedPublications section updated: two new references were added (Lancet 2016 ibrutinib vs temsirolimus; Lancet Oncology 2015 blinatumomab) and the previous two references were removed.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedAdded a new Locations section listing study sites by state (Arizona, California, Colorado, Florida, Georgia, Illinois, Massachusetts, Michigan, New Jersey, New York, North Carolina, Ohio, Oregon, Pennsylvania, Tennessee, Texas, Washington) and revised the page revision to v3.3.3. The previous separate state location headings were removed.SummaryDifference1%

- Check52 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page, with no substantive changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check59 days agoChange DetectedPublications section wording was slightly reworded and the revision tag updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check66 days agoChange DetectedThe notice about government funding and NIH operating status has been removed from the page; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to ZUMA-2 Study Brexuca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZUMA-2 Study Brexuca Clinical Trial page.